Keywords: Ratiopharm, M&A, Sanofi-Aventis, Teva, Mylan, Actavis, Germany

Several bidders line up for Germany’s Ratiopharm

Article | 12 November 2009

Print This

There now seems to be positive action in the takeover of German generic drugmaker Ratiopharm GmbH, which was put up ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in